Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factors

Valerio De Stefano, M. Ruggeri, A. Tosetto, F. Palandri, N. Polverelli, M. G. Mazzucconi, C. Santoro, G. Gaidano, M. Lunghi, F. Zaja, R. Sartori, P. Fazi, F. Rodeghiero

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

An increased risk of thrombosis has been reported in primary immune thrombocytopenia (ITP) and with the use of thrombopoietin (TPO) receptor agonists, on the basis of population studies using administrative databases.
Original languageEnglish
Pages (from-to)1266-1273
Number of pages8
JournalJournal of Thrombosis and Haemostasis
Volume12
DOIs
Publication statusPublished - 2014

Keywords

  • TMP mimetic peptide
  • epidemiology
  • immune thrombocytopenic purpura
  • splenectomy
  • thrombosis

Fingerprint

Dive into the research topics of 'Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factors'. Together they form a unique fingerprint.

Cite this